Terms: = Breast cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1
171 results:
1. Performance of a multigene genomic classifier and clinical parameters in predicting malignancy in a Southeast Asian cohort of patients with cytologically indeterminate thyroid nodules.
Yang SP; Nga ME; Bundele MM; Chiosea SI; Tan SH; Lum JHY; Parameswaran R; Lim MY; Li H; Cheah WK; Sek KS; Tan ATH; Loh TKS; Ngiam KY; Tan WB; Huang X; Ho TWT; Lim KH; Lim CM; Singaporewalla RM; Rao AD; Rao NCL; Chua DYK; Chin DC; Wald AI; LiVolsi VA; Nikiforov YE; Tai ES
Cancer Cytopathol; 2024 May; 132(5):309-319. PubMed ID: 38319805
[TBL] [Abstract] [Full Text] [Related]
2. Mucinous cystadenocarcinoma of the breast harbours TRPS1 expressions and PIK3CA alterations.
Chen WY; Hu YH; Tsai YH; Hang JF; Tan PH; Chen CJ
Histopathology; 2024 Feb; 84(3):550-555. PubMed ID: 37983855
[TBL] [Abstract] [Full Text] [Related]
3. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
4. RAS‑stimulated release of exosomal
Kim O; Tran PT; Gal M; Lee SJ; Na SH; Hwangbo C; Lee JH
Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37503759
[TBL] [Abstract] [Full Text] [Related]
5. Gene Expression Profiling of Fibroepithelial Lesions of the breast.
Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386
[TBL] [Abstract] [Full Text] [Related]
6. Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines.
Tawfeeq N; Lazarte JMS; Jin Y; Gregory MD; Lamango NS
Oncotarget; 2023 Mar; 14():243-257. PubMed ID: 36961909
[TBL] [Abstract] [Full Text] [Related]
7. Role of a Mixture of Polyphenol Compounds Released after Blueberry Fermentation in Chemoprevention of Mammary Carcinoma: In Vivo Involvement of miR-145.
Mallet JF; Shahbazi R; Alsadi N; Saleem A; Sobiesiak A; Arnason JT; Matar C
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835085
[TBL] [Abstract] [Full Text] [Related]
8. p38 Mitogen-Activated Protein Kinase Signaling Enhances Reovirus Replication by Facilitating Efficient Virus Entry, Capsid Uncoating, and Postuncoating Steps.
Mohamed A; Lin QF; Eaton HE; Shmulevitz M
J Virol; 2023 Feb; 97(2):e0000923. PubMed ID: 36744961
[TBL] [Abstract] [Full Text] [Related]
9. Spontaneous rupture of a solitary oligometastatic hepatic melanoma.
Tiong J; Rajagopalan A; Jaya J; Sritharan M
BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36731945
[TBL] [Abstract] [Full Text] [Related]
10. Lipid raft protein flotillin-1 is important for the interaction between SOS1 and H-Ras/K-Ras, leading to Ras activation.
Jin H; Koh M; Lim H; Yong HY; Kim ES; Kim SY; Kim K; Jung J; Ryu WJ; Choi KY; Moon A
Int J Cancer; 2023 May; 152(9):1933-1946. PubMed ID: 36691829
[TBL] [Abstract] [Full Text] [Related]
11. Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer.
Sivakumar S; Jin DX; Tukachinsky H; Murugesan K; McGregor K; Danziger N; Pavlick D; Gjoerup O; Ross JS; Harmon R; Chung J; Decker B; Dennis L; Frampton GM; Molinero L; Oesterreich S; Venstrom JM; Oxnard GR; Hegde PS; Sokol ES
Nat Commun; 2022 Dec; 13(1):7495. PubMed ID: 36470901
[TBL] [Abstract] [Full Text] [Related]
12. Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations.
Li K; Cao L; Li C; Wu J; Chen B; Zhang G; Li X; Wen L; Jia M; Wei G; Lin J; Li Y; Zhang Y; Mok H; Ren C; Wang Y; Qi X; Guo L; Che Y; Liao N
Cancer Med; 2023 Mar; 12(5):5195-5208. PubMed ID: 36404592
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing.
Akkad N; Kodgule R; Duncavage EJ; Mehta-Shah N; Spencer DH; Watkins M; Shirai C; Myckatyn TM
Aesthet Surg J; 2023 Feb; 43(3):318-328. PubMed ID: 36351182
[TBL] [Abstract] [Full Text] [Related]
14. Elevated nras expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness.
Zheng ZY; Elsarraj H; Lei JT; Hong Y; Anurag M; Feng L; Kennedy H; Shen Y; Lo F; Zhao Z; Zhang B; Zhang XH; Tawfik OW; Behbod F; Chang EC
Breast Cancer Res; 2022 Oct; 24(1):68. PubMed ID: 36258226
[TBL] [Abstract] [Full Text] [Related]
15. Induction of apoptosis and suppression of Ras gene expression in MCF human breast cancer cells.
Saremi S; Kolahi M; Tabandeh MR; Hashemitabar M
J Cancer Res Ther; 2022; 18(4):1052-1060. PubMed ID: 36149161
[TBL] [Abstract] [Full Text] [Related]
16. Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Musacchio L; Califano D; Bartoletti M; Arenare L; Lorusso D; Losito NS; Cormio G; Greggi S; Raspagliesi F; Valabrega G; Salutari V; Pisano C; Spina A; Russo D; Del Sesto M; Canzonieri V; Ferraù F; Zannoni GF; Loizzi V; Ghizzoni V; Casanova C; Tuninetti V; Ducceschi M; Del Vecchio V; Scalone S; Priolo D; Perrone F; Scambia G; Pignata S
Br J Cancer; 2022 Nov; 127(8):1479-1486. PubMed ID: 35869143
[TBL] [Abstract] [Full Text] [Related]
17. Validation of a DNA-Based Next-Generation Sequencing Test for Molecular Diagnostic Variant and Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tissue Specimens and Liquid Biopsy Plasma/Cell-Free DNA Samples.
Werner TV; Kock S; Weber I; Kayser G; Werner M; Lassmann S
J Mol Diagn; 2022 Jul; 24(7):784-802. PubMed ID: 35787794
[TBL] [Abstract] [Full Text] [Related]
18. Strategies for Targeting KRAS: A Challenging Drug Target.
Wadood A; Ajmal A; Rehman AU
Curr Pharm Des; 2022; 28(23):1897-1901. PubMed ID: 35524675
[TBL] [Abstract] [Full Text] [Related]
19. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
[TBL] [Abstract] [Full Text] [Related]
20. KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer.
Shimozaki K; Shinozaki E; Yamamoto N; Imamura Y; Osumi H; Nakayama I; Wakatsuki T; Ooki A; Takahari D; Ogura M; Chin K; Watanabe M; Yamaguchi K
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1273-1283. PubMed ID: 35438321
[TBL] [Abstract] [Full Text] [Related]
[Next]
